Bank Of America Corp Matinas Bio Pharma Holdings, Inc. Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.15 - $0.37 $12,173 - $30,028	-81,158 Reduced 62.49%	48,707 $7,000
Q1 2024 May 15, 2024	BUY	$0.19 - $0.3 $24,622 - $38,877	129,593 Added 47644.49%	129,865 $35,000
Q4 2023 Feb 14, 2024	BUY	$0.12 - $0.64 $32 - $174	272 New	272 $0
Q1 2023 May 12, 2023	SELL	$0.39 - $0.6 $360 - $555	-925 Reduced 99.36%	6 $0
Q4 2022 Feb 10, 2023	SELL	$0.46 - $42.69 $333 - $30,907	-724 Reduced 43.75%	931 $0
Q3 2022 Nov 14, 2022	SELL	$0.63 - $33.0 $1,249 - $65,439	-1,983 Reduced 54.51%	1,655 $1,000
Q1 2022 May 16, 2022	SELL	$0.5 - $1.06 $71,355 - $151,272	-142,710 Reduced 97.51%	3,638 $3,000
Q4 2021 Feb 08, 2022	BUY	$0.92 - $1.22 $132,963 - $176,320	144,525 Added 7927.87%	146,348 $148,000
Q3 2021 Nov 15, 2021	BUY	$0.67 - $1.51 $1,169 - $2,634	1,745 Added 2237.18%	1,823 $2,000
Q2 2021 Sep 13, 2021	BUY	$0.75 - $1.1 $58 - $85	78 New	78 $0

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.